Filing Details
- Accession Number:
- 0001127602-20-010127
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-10 17:46:43
- Reporting Period:
- 2020-03-06
- Accepted Time:
- 2020-03-10 17:46:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1713517 | Jacqueline Scanlan | 125 Summer Street Boston MA 02110 | Svp, Global Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-06 | 1,299 | $38.43 | 6,007 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-06 | 1,299 | $100.50 | 4,708 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-09 | 118 | $98.00 | 4,590 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-10 | 207 | $99.63 | 4,383 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-03-06 | 1,299 | $0.00 | 1,299 | $38.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,300 | 2020-03-06 | 2024-03-06 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing 10b5-1 trading plan.
- This number includes unvested restricted stock units previously reported and 13 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2019.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Billionaire Hedge Funds
